Hope for Parkinson's and Alzheimer's Patients: An In-Depth Interview with Cuong Do, CEO of BioVie.
Jun. 10, 2024
In this exclusive interview, Cuong Do, CEO of Biovie (BIVI), shares groundbreaking insights into the company's innovative approach to treating Parkinson's and Alzheimer's diseases. Learn about the promising new therapy, Bezithium, and its potential to revolutionize Parkinson's treatment. Discover the latest developments in Biovie's clinical trials, including a Phase 2B study and a significant grant from the Department of Defense for Long COVID research. Cuong Do also discusses Biovie's strategic vision for the future, highlighting the company's commitment to advancing healthcare and improving patient outcomes. Don't miss this in-depth conversation about the future of biotech and the exciting opportunities ahead for Biovie.
